CD206 Polyclonal antibody
CD206 Polyclonal Antibody for FC, WB, ELISA
Host / Isotype
Rabbit / IgG
human, mouse, rat and More (2)
WB, IF, FC, ELISA
Cat no : 18704-1-AP
|Positive WB detected in||mouse liver tissue, human placenta tissue, human kidney tissue, rat liver tissue|
|Positive FC detected in||RAW 264.7 cells|
|Western Blot (WB)||WB : 1:500-1:1000|
|Sample-dependent, check data in validation data gallery|
|WB||See 78 publications below|
|IHC||See 53 publications below|
|IF||See 130 publications below|
|FC||See 12 publications below|
18704-1-AP targets CD206 in WB, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse, rat, mussel, pig|
|Host / Isotype||Rabbit / IgG|
|Full Name||mannose receptor, C type 1|
|Calculated molecular weight||166 kDa|
|Observed molecular weight||165-180 kDa|
|GenBank accession number||NM_002438|
|Gene ID (NCBI)||4360|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
CD206 (macrophage mannose receptor 1) is a lectin-type endocytic receptor expressed on selected macrophages, dendritic cells, and non-vascular endothelium and plays a role in antigen processing and presentation, phagocytosis, and intracellular signaling.
1. What is the molecular weight of CD206?
The molecular size of full-length CD206 is 170-180 kDa, depending on the exact tissue-specific glycosylation pattern (PMID: 19427834). Additionally, CD206 can be cleaved off and a soluble form (sMR) lacking the tail, with a slightly lower molecular weight, can be released to the cell medium (PMID: 9722572).
2. What is the subcellular localization of CD206?
CD206 is a type I membrane protein composed of a large extracellular multidomain, a transmembrane domain, and a short cytoplasmic tail. It is present at the plasma membrane and in endosomes, as CD206 undergoes constant recycling between the plasma membrane and endosomal compartment.
3. Is CD206 post-translationally modified?
CD206 undergoes quite extensive post-translational modifications, predominantly N-linked glycosylation that affects ligand binding recognition and affinity (PMID: 22966131).
4. Can CD206 marker be used as a marker of M2 macrophages?
The activation of macrophages with various stimuli leads to their polarization into classical (M1) or alternatively activated (M2) subtypes spectrums and both subtypes differ in their regulatory and effector functions (PMID: 24669294). Pathogens and IFN-γ promote M1 polarization, while IL-4 released during parasite infections and allergen response promotes M2 polarization. Classically, the markers of M2 macrophages include CD206, as well as arginase-1 (ARG1; https://www.ptglab.com/products/ARG1-Antibody-16001-1-AP.htm), CD163 (https://www.ptglab.com/products/CD163-Antibody-16646-1-AP.htm), and thrombospondin 1 (TSP1/ THBS1; https://www.ptglab.com/products/TSP1-Antibody-18304-1-AP.htm).
5. How can you polarize macrophages into M2 direction?
One of the most commonly used methods is stimulation by the addition of IL-4 cytokine. We recommend using our animal-free human IL-4 (https://www.ptglab.com/products/recombinant-human-il-4.htm).
|Product Specific Protocols|
|WB protocol for CD206 antibody 18704-1-AP||Download protocol|
|FC protocol for CD206 antibody 18704-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Inhibition of LTβR signalling activates WNT-induced regeneration in lung.
Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity.
Carrier-Free Immunotherapeutic Nano-Booster with Dual Synergistic Effects Based on Glutaminase Inhibition Combined with Photodynamic Therapy
Adv Sci (Weinh)
Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages.
Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction.
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target.
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
Murali (Verified Customer) (07-28-2022)
This amazing antibody works well for human IHC staining.
Uthra (Verified Customer) (10-14-2021)
The antibody works fine for IF.
Nethaji (Verified Customer) (05-08-2019)
The antibody works fine for western and ICC.